LANCRIX

5-Aza-2'-Deoxycytidine, ≥99%

Catalog No. 030807

Identification
Synonyms2′-Deoxy-5-azacytidine
CAS No.2353-33-5
M.F.

C8H12N4O4

M.W.228.21
Beilstein No.617982
EC No.219-089-4
MDL No.MFCD00043011
PubChem Substance ID24890797
Technical Data
AppearanceWhite crystalline powder
Assay≥99%
SolubilitySoluble to 50 mM in water and to 50 mM in DMSO
StorageProtected from light
Safety Data
SymbolGHS08GHS07
Hazard StatementsH302-H315-H319-H335-H341-H360
Precautionary StatementsP201-P261-P281-P305 + P351 + P338-P308 + P313
Hazard SymbolsT
Risk StatementsR61-22-36/37/38-68
Safety StatementsS26-36/37
WGK Germany3
RTECSXZ3012000
Reference

Jackson-Grusby et al (1997) Mutagenicity of 5-aza-2'-deoxycytidine is mediated by the mammalian DNA methyltransferase. Proc.Natl.Acad.Sci.USA 94 4681.

Bender et al (1998) Inhibition of DNA methylation by 5-aza-2'-deoxycytidine supresses the growth of human tumour cell lines. Cancer Res. 58 95. PMID: 9426064.

Momparler (2005) Pharmacology of 5-aza-2'-deoxycytidine (decitabine). Semin.Hematol. 42 (Suppl 2) S9. PMID: 16015507.

Availability: Ships in 1-3 days

For research use only.

Inquire

(*Required Field)
*Name
*Organization Name
*Country
*Email Address
Phone
Subject 030807, 5-Aza-2'-Deoxycytidine, ≥99%, 2353-33-5
*Message
*Code If it’s not clear, please click on the picture to change one.